|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Access Pharmaceuticals Inc., of Dallas, submitted a premarket notification 510(k) application to the FDA to market MuGard, an oral rinse for the prevention and treatment of oral mucositis, which affects more than 20 percent of cancer patients undergoing radiation and chemotherapy. The company is actively seeking marketing partners for this product.
o Arbor Vita Corp., of Sunnyvale, Calif., said the National Institutes of Health awarded the firm about $900,000 to develop and commercialize an in vitro diagnostic test for cervical pre-cancer and cancer. The Phase II SBIR grant will fund the company's test based on detection of the HPV-E6 oncoprotein, identified as ...